Form 4: Acrivon Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Acrivon Therapeutics' Chief Legal Officer, Mary Miller, sold 184 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Mary Miller, the Chief Legal Officer of Acrivon Therapeutics, sold 184 shares of common stock on November 14, 2024.
• The shares were sold at a price of $7.92 per share.
• This transaction was to cover mandatory tax withholding requirements upon the vesting of restricted stock units.
• Following the transaction, Ms. Miller directly owns 37,941 shares of Acrivon Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Similar transactions are common among executives at publicly traded companies, particularly when restricted stock units vest.
• The sale of shares to cover tax obligations is a standard practice and does not necessarily indicate a change in the executive's outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Acrivon Therapeutics, stock sale, insider trading, Form 4, Mary Miller, tax withholding, restricted stock units